Development and evaluation of a generic population pharmacokinetic model for standard half-life factor VIII for use in dose individualization

Ways to Fit a PK Model with Some Data Below the Quantification Limit

Stuart L. Beal · Journal of Pharmacokinetics and Pharmacodynamics · 2001 · 1.1K citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +14

Break‐through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A

P. Collins, Victor S. Blanchette, Kathelijn Fischer et al. · Journal of Thrombosis and Haemostasis · 2008 · 324 citations

Medicine, Hematology, Hemostasis +12

A study of variations in the reported haemophilia A prevalence around the world

Jeffrey S. Stonebraker, Paula Bolton‐Maggs, J. Michael Soucie et al. · Haemophilia · 2009 · 292 citations

Public Health, Health Sciences, Hematology +10

Haemophilia in Sweden VII. Incidence, Treatment and Prophylaxis of Arthropathy and other Musculo-Skeletal Manifestations of Haemophilia A and B

A Ahlberg · Acta Orthopaedica Scandinavica · 1965 · 253 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +10

Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight

Sven Björkman, Myungshin Oh, Gerald Spotts et al. · Blood · 2011 · 204 citations · Full text

Pharmacy, Hematology, Pharmacokinetics +16